Active Fibroblast Growth Factor 4 (FGF4) Homo sapiens (Human) Active protein

HBGF4; HST; HSTF1; KFGF; K-FGF; Heparin Secretory Transforming Protein 1; Kaposi Sarcoma Oncogene; Transforming Protein KS3; FGF-Related Oncogene

Add to Cart Distributors
Overview
Properties
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder, Purity > 90%
  • Isoelectric Point8.5
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Active Fibroblast Growth Factor 4 (FGF4) Packages (Simulation)
  • Active Fibroblast Growth Factor 4 (FGF4) Packages (Simulation)
  • APA034Hu01.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Activity test

Fibroblast Growth Factor 4 (FGF4) is a secreted signaling protein belonging to the fibroblast growth factor family, which plays crucial roles in embryonic development, cell proliferation, differentiation, and migration. It is particularly important during limb formation, mesoderm patterning, and stem cell maintenance. FGF4 exerts its biological functions by binding and activating specific FGF receptors (FGFRs) with high affinity. FGF4 specifically binds to Fibroblast Growth Factor Receptor 2 (FGFR2), particularly the IIIc isoform, triggering receptor dimerization, autophosphorylation, and subsequent activation of downstream signaling pathways including MAPK and PI3K-AKT.To detect the activity of recombinant FGF4 , a functional ELISA assay was performed to evaluate the interaction between recombinant human FGF4 and recombinant rat FGFR2.Briefly, FGF4 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to FGFR2-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-FGF4 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 µL stop solution to the wells and read at 450/630nm immediately. The binding activity of recombinant human FGF4 and recombinant rat FGFR2 was shown in Figure 1, the EC50 for this effect is 0.612 µg/mL.

Usage

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Fibroblast Growth Factor 4 Is Required but not Sufficient for the Astrocyte DedifferentiationSpringer: Source
  • Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancerpubmed:28445992
  • Functional Characterization of VEGF- and FGF-induced Tumor Blood Vessel Models in Human Cancer Xenograftspubmed:29187438

Recommend products